Isotretinoin Prescribing Guidelines

Patient Eligibility and Dosing Strategy

The American Academy of Dermatology recommends initiating isotretinoin at 0.5 mg/kg/day for the first month, then increasing to 1.0 mg/kg/day as tolerated, targeting a cumulative dose of 120-150 mg/kg over 15-20 weeks to minimize relapse rates 1, 2
For patients with severe nodulocystic acne, the American Academy of Dermatology suggests starting at 0.5 mg/kg/day for month 1, then increasing to 1.0 mg/kg/day as tolerated 1, 2
The cumulative dose of 120-150 mg/kg is associated with lower relapse rates than lower cumulative doses, according to the American Academy of Dermatology 1, 2

The American Academy of Dermatology recommends baseline testing, including liver function tests, fasting lipid panel, and pregnancy test for patients with pregnancy potential 3, 2
Monthly pregnancy tests are mandatory throughout treatment and one month post-therapy for patients with pregnancy potential, as recommended by the American Academy of Dermatology 3, 2
The American Academy of Dermatology suggests monitoring liver function tests and fasting lipid panel at baseline and at least once during treatment, though monthly monitoring is recommended 3, 2

The American Academy of Dermatology reports that cheilitis, dry skin, dry eyes, and nasal dryness are dose-dependent and nearly universal, but temporary and resolve after discontinuation 1, 3, 2
The American Academy of Dermatology recommends liberal use of emollients, lip balm, and ocular lubricants to manage mucocutaneous effects 2
Myalgias occur in up to 25% of patients on high-dose therapy, but symptoms generally resolve after discontinuation, according to the American Academy of Dermatology 2

The American Academy of Dermatology states that pregnancy is an absolute contraindication (Category X) 3
The American Academy of Dermatology recommends using isotretinoin with caution in patients with genetic predisposition for osteoporosis, history of childhood osteoporosis, osteomalacia, or bone metabolism disorders 4
Diabetic patients require more frequent glucose monitoring when using isotretinoin, as recommended by the British Association of Dermatologists 4

The American Academy of Dermatology warns of the risk of pseudotumor cerebri when using isotretinoin with tetracyclines 3
The American Academy of Dermatology advises against using vitamin A supplements due to the risk of hypervitaminosis A 3
The American Academy of Dermatology recommends avoiding methotrexate, alcohol, keratolytic agents, and photosensitizing medications when using isotretinoin 3